Navigation Links
Possible new approach to purifying drinking water
Date:6/3/2008

DURHAM, N.C. A genetic tool used by medical researchers may also be used in a novel approach to remove harmful microbes and viruses from drinking water.

In a series of proof-of-concept experiments, Duke University engineers demonstrated that short strands of genetic material could successfully target a matching portion of a gene in a common fungus found in water and make it stop working. If this new approach can be perfected, the researchers believe that it could serve as the basis for a device to help solve the problem of safe drinking water in Third World countries without water treatment facilities.

The relatively new technology, known as RNA interference (RNAi), makes use of short snippets of genetic material that match -- like a lock and key -- a corresponding segment of a gene in the target. When these snippets enter a cell and attach to the corresponding segment, they can inhibit or block the action of the target gene. This approach is increasingly being used as a tool in biomedical research, but has not previously been applied to environmental issues.

Pathogens, whether bacterial or viral, represent one of the major threats to drinking water in developed and undeveloped countries, said Sara Morey, a Ph.D. candidate in the lab of Claudia Gunsch, assistant professor of civil engineering at Dukes Pratt School of Engineering. Our data showed that we could silence the action of a specific gene in a fungus in water, leading us to believe that RNAi shows promise as a gene-silencing tool for controlling the proliferation of waterborne bacteria and viruses.

Morey presented the results of her experiments June 3, 2008, during the annual meeting of the American Society of Microbiology in Boston.

In addition to helping solve drinking water issues in underdeveloped countries, this new approach could also address some of the drawbacks associated with treated drinking water in more developed nations, Morey said. Methods currently used to treat water -- chlorine and ultraviolet (UV) light -- can be expensive to operate and the results of the treatment itself can affect the taste and smell of the water.

Although these methods have been employed for years, problems can emerge once the treated water enters the distribution system, where pathogens are also present. For this reason, water is often over-chlorinated at the plant so that it remains in high enough concentrations in the pipes to neutralize pathogens. This explains why people living the closer to a treatment plant will be more likely to taste or smell the chemical than those farthest away from the plant, the researchers said. Additionally, chlorine can react with other organic matter in the system, leading to potentially harmful by-products.

UV light, while also effective in neutralizing pathogens at the plant, has no effect once the water is pumped out of the plant. Gunsch said that many pathogens are developing a resistance to the effects of chlorine and UV light, so newer options are needed.

We envision creating a system based on RNAi technology that would look from the outside just like the water filters commonly used now, Gunsch said. This approach would be especially attractive in less industrialized countries without water treatment systems. This point-of-use strategy would allow these countries to make safe water without the expense of water purification infrastructure.

The first prototypes would likely involve a filter seeded with RNAi that would eliminate pathogens as the water passed through it. These filters would likely need to be replaced regularly, Gunsch said, adding that she believes it would theoretically be possible to create a living, or self-replicating system, which would not require replacement.

The researchers are currently conducting additional experiments targeting other regions of the fungus genome. For their proof-of-concept experiments, they tested RNAi on a non-essential, yet easy to monitor, gene. They are now testing this approach to silence or block genes essential to the viability of the pathogen.

They are also planning to test this strategy in water that contains a number of different pathogens at the same time, as well as trying to determine the optimal concentration needed in the water to be effective.


'/>"/>

Contact: Richard Merritt
richard.merritt@duke.edu
919-660-8414
Duke University
Source:Eurekalert  

Related biology technology :

1. Is Earlier Detection of Cancers Such as Glioma Possible?
2. Femtogram-level chemical measurements now possible, U. of I. team reports
3. NIST team proves bridge from conventional to molecular electronics possible
4. Possible New Way to Detect, Monitor Liver Disease Without Painful Liver Biopsy
5. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
6. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
7. Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry
8. Abbott Scientists Present a New Approach for Treating Attention-Deficit Hyperactivity Disorder
9. Novel Approach to Treat Alzheimers and Other Diseases Offered by Targeting Cell Membrane RAFTS
10. Countering an approaching water crisis
11. Quiznos Selects Halogen for Fresh Approach to Talent Management
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Possible new approach to purifying drinking water
(Date:2/23/2017)... 23, 2017 /PRNewswire/ - The Fight Against Cancer Innovation ... (OICR) are pleased to report that Fusion Pharmaceuticals Inc. ... Johnson & Johnson Innovation – JJDC, Inc. (JJDC) as ... HealthCap, TPG Biotechnology Partners, and Genesys Capital, as well ... ...
(Date:2/23/2017)... ... February 23, 2017 , ... Brain Sentinel, Inc. ... marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting System. The ... facilities during periods of rest. A lightweight, non-invasive monitor is placed on the ...
(Date:2/23/2017)... LOS ANGELES , Feb. 23, 2017  Capricor Therapeutics, ... cardiac and other medical conditions, today announced that Linda Marbán, ... at two upcoming investor conferences: Cowen ... 2017 at 10:00 am ET Boston, MA ... 14, 2017 at 9:00 am PT (12:00 pm ET) ...
(Date:2/22/2017)... ... February 22, 2017 , ... Kernel , a human ... LLC (KRS) clinical development program. KRS is a neurotechnology spin-out from the ... clinical applications. The terms of the transaction were not disclosed. , It ...
Breaking Biology Technology:
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
Breaking Biology News(10 mins):